Answers are grounded in this paper and cite their sources.
Immunological parameters in participants that entered the maintenance phase (n = 16). Levels at enrolment, upon induction and during maintenance and post-therapy follow-up of total lymphocytes absolute number (10³ cells/μL; A), CD4⁺ (B) CD8⁺, and (C) T-cell number (cells/μL), CD4⁺/CD8⁺ ratio (D), B- (E), and NK- (F) cell number (cells/μL). Data are presented as box plots. Wilcoxon signed rank sum test for paired data and Mann–Whitney test were used for the analyses. P values assess the changes from enrolment and from baseline of maintenance within responders and progressors and differences between responders and progressors at each time point.
No takes yet. Share an insight, caveat, or question.
Sgadari et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: